vimarsana.com
Home
Live Updates
Steven Seedhouse - Breaking News
Pages:
7
8
9
10
11
12
13
Page 6 - Steven Seedhouse News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Gene Editing Is Working Wall Street Is Taking Notice
Shares of Crispr Therapeutics are up 45% this year, compared with the Nasdaq Composite's 31% rise.
United states
Steven seedhouse
Raymond james
Vertex pharmaceuticals
Drug administration
European hematology association
Wall street
Crispr therapeutics
Nasdaq composite
Nobel prize winning
Intellia therapeutics
Saharan african
Editas medicine
Beam therapeutics
Bill alpert
FDA staff unsure NASH drug s modest benefits outweigh safety risks
BioPharma
United states
Brian skorney
Steven seedhouse
Michael yee
Raymond james
Madrigal pharmaceuticals
Intercept pharmaceuticals
Drug administration
Viking therapeutics
Akero therapeutics
Apellis reports strong start for new vision loss drug
BioPharma
Raymond james
Jon miller
Iveric bio
Steven seedhouse
Astellas pharma
Drug administration
Dive brief
Apellis pharmaceutical
Wall street
Umer raffat
Why InflaRx Stock Skyrocketed This Week
The biopharmaceutical company's near-term sales outlook has gotten a huge boost following Emergency Use Authorization for one of its drugs.
Guggenheim yatin suneja
Raymond james
Inflarx gohibic
Steven seedhouse
Drug administration
Emergency use authorization
Yatin suneja
StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy
Nine analysts raise stock price targets for Apellis Pharmaceuticals after it wins the FDA's first approval for a geographic atrophy therapy.
Peter stein
Raymond james
Iveric bio
Annabel samimy
Steven seedhouse
Yigal nochomovitz
Robertw baird
Laura chico
Chris howerton
Chirinjeev kathuria
Doug tsao
Colleen kusy
Tazeen ahmad
Jackk allen
Brian culley
Ib chemoprotection
vimarsana © 2020. All Rights Reserved.